AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
44 hedge funds and large institutions have $16M invested in AVEO Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Holders
44
Holding in Top 10
3
Calls
$8K
Puts
–
Top Buyers
| 1 | +$667K | |
| 2 | +$156K | |
| 3 | +$99K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26.1K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$9.83K |
Top Sellers
| 1 | -$200K | |
| 2 | -$91.2K | |
| 3 | -$35.4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$29.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$28.9K |